These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 5704709)
1. [Treatment of inoperable phthisics by transparietal intracavitary continuous drip administration of bacteriostatics]. Favez G; Elias W Schweiz Med Wochenschr; 1968 Nov; 98(47):1851-4. PubMed ID: 5704709 [No Abstract] [Full Text] [Related]
2. [Use of low doses of tibon in the antibacterial therapy of pulmonary tuberculosis]. Murik SO; Granat AI Probl Tuberk; 1977 Jun; (6):53-5. PubMed ID: 882563 [No Abstract] [Full Text] [Related]
3. [Results of antibacterial treatment of pulmonary tuberculosis in patients with primary resistance to drugs]. Mysakowska H; Pietroń E; Sikora-Rózyńska M; Smaga M; Litwin B; Rybicka-Stryjecka Z Pol Tyg Lek; 1965 May; 20(19):686-8. PubMed ID: 5844021 [No Abstract] [Full Text] [Related]
4. [Evaluation of the therapeutic effects of secondary antitubercular agents]. Watanabe S; Nosaki M; Iwasaki M; Hamano S; Furuya Y Iryo; 1966 Mar; 20(3):251-6. PubMed ID: 5965119 [No Abstract] [Full Text] [Related]
5. [Method of selective endobronchail administration of antitubercular agents in carvernous lesions]. Ufimtseva TD Probl Tuberk; 1975; (1):21-4. PubMed ID: 1144361 [No Abstract] [Full Text] [Related]
6. [Bacterial resistance tests against secondary antitubercular agents--reliability of the routine methods]. Tsukamura M Iryo; 1966 Mar; 20(3):241-50. PubMed ID: 5964831 [No Abstract] [Full Text] [Related]
7. [Results of treatment in new cases of pulmonary tuberculosis registered in 1963 at the Antitubercular Dispensary of the Wola District of Warsaw]. Rose A Gruzlica; 1967 Dec; 35(12):1251-6. PubMed ID: 6081907 [No Abstract] [Full Text] [Related]
8. [Action of thiazine (150 mg thiosemicarbazone plus 300 mg INH) in pulmonary tuberculosis and results obtained in Turkey]. Ozgen ZS Ftiziologia; 1971; 20(2):139-42. PubMed ID: 5164048 [No Abstract] [Full Text] [Related]
9. [Observations on antituberculous drug-resistance among pulmonary tuberculosis patients at the National Sanatoria in Kyushu district. 3. The secondary anti-tuberculosis agents (kanamycin, cycloserine, ethionamide)]. Yamaguchi S Iryo; 1968 Oct; 22(10):1115-9. PubMed ID: 5715475 [No Abstract] [Full Text] [Related]
10. [A comparison of the effects of the combined therapy with CPM+1321 TH+CS, KM+1321 TH+CS and KM+1314 TH+CS in the treatment of pulmonary tuberculosis]. Iizuka Y; Iwasaki T; Fujioka K Kekkaku; 1969 Mar; 44(3):109-15. PubMed ID: 5783307 [No Abstract] [Full Text] [Related]
11. [Changes in drug resistance of Mycobacteria in the simultaneous use of chemotherapy and intravenous infusions of dissolved ozone]. Belianin II; Shmelev EI Probl Tuberk Bolezn Legk; 2004; (7):32-5. PubMed ID: 15379039 [TBL] [Abstract][Full Text] [Related]
12. [Results of the treatment in patients with pulmonary tuberculosis excreting bacilli in primary resistance to antitubercular drugs]. Hornung S; Polończyk M Gruzlica; 1965 Oct; 33(10):886-9. PubMed ID: 5881604 [No Abstract] [Full Text] [Related]